Randomized Trial of Late Surfactant Treatment in Ventilated Preterm Infants Receiving Inhaled Nitric Oxide

Objective To assess whether late surfactant treatment in extremely low gestational age (GA) newborn infants requiring ventilation at 7-14 days, who often have surfactant deficiency and dysfunction, safely improves survival without bronchopulmonary dysplasia (BPD). Study design Extremely low GA newbo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of pediatrics 2016-01, Vol.168, p.23-29.e4
Hauptverfasser:	Ballard, Roberta A., MD, Keller, Roberta L., MD, Black, Dennis M., PhD, Ballard, Philip L., MD, PhD, Merrill, Jeffrey D., MD, Eichenwald, Eric C., MD, Truog, William E., MD, Mammel, Mark C., MD, Steinhorn, Robin H., MD, Rogers, Elizabeth E., MD, Ryan, Rita M., MD, Durand, David J., MD, Asselin, Jeanette M., MS, RRT-NPS, Bendel, Catherine M., MD, Bendel-Stenzel, Ellen M., MD, Courtney, Sherry E., MD, Dhanireddy, Ramasubbareddy, MD, Hudak, Mark L., MD, Koch, Frances R., MD, Mayock, Dennis E., MD, McKay, Victor J., MD, O'Shea, T. Michael, MD, Porta, Nicolas F., MD, Wadhawan, Rajan, MD, Palermo, Lisa, MS
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Inhalation Bronchopulmonary Dysplasia - epidemiology Bronchopulmonary Dysplasia - etiology Female Humans Infant, Newborn Infant, Premature Infant, Premature, Diseases - mortality Infant, Premature, Diseases - therapy Infant, Very Low Birth Weight Male Nitric Oxide - administration & dosage Nitric Oxide - adverse effects Pediatrics Pulmonary Surfactants - adverse effects Pulmonary Surfactants - therapeutic use Respiration, Artificial - adverse effects Respiration, Artificial - mortality Survival Rate United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!